InvestorsHub Logo

DewDiligence

11/21/16 9:29 AM

#206218 RE: haysaw #204734

ACOR -7% on discontinuation of Dalfampridine for post-stroke walking difficulties:

http://finance.yahoo.com/news/acorda-discontinue-development-dalfampridine-treatment-110000565.html